Emtricitabine Impurity 12
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

2216-52-6Emtricitabine Impurity 12

● In Stock

Catalogue No.:VL54013
CAS No.:2216-52-6
Mol. Formula:C10H20O
Mol. Weight:156.27 g/mol

Additional information on CAS 2216-52-6

Parent drug

Emtricitabine

IUPAC Name

(1S, 2S, 5R)-2-isopropyl-5-methylcyclohexanol

Synonyms

(+)-Neomenthol

Description

Emtricitabine Impurity 12 (CAS No.2216-52-6) is a nucleoside reverse transcriptase inhibitor (NRTI) in combination with other antiviral agents it shows activity against HIV. It is approved for use in combination therapy.

References

“Sax, Paul E., et al. “Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Dolutegravir with Emtricitabine and Tenofovir Alafenamide, for Initial Treatment of HIV-1 Infection (GS-US-380–1490): A Randomised, Double-Blind, Multicentre, Phase 3, Non-Inferiority Trial.†The Lancet, vol. 390, no. 10107, Nov. 2017, pp. 2073–82, https://doi.org/10.1016/s0140-6736(17)32340-1. Bang, Lynne M., and Lesley J. Scott. “Emtricitabine.†Drugs, vol. 63, no. 22, 2003, pp. 2413–24, https://do

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form